Align Technology
ALGN

Align Technology (ALGN) stock price, chart and financials

Price chart

+11.29% over 1Y
Oct 14, 2025Low $128.43 · High $197.51Oct 14, 2026

Financials

Company profile

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Frequently asked questions

  • Is Align Technology (ALGN) profitable?

    Yes. Align Technology earned $413.6M in net income over the trailing twelve months, a net margin of 9.99%.

  • How much revenue does Align Technology (ALGN) make?

    Align Technology generated $4.1B in revenue over the trailing twelve months, up 4.32% year over year.

  • What is ALGN's P/E ratio?

    Align Technology trades at 24.8 times trailing twelve-month earnings, on an EPS of $5.77.

  • How do I buy stock in Align Technology (ALGN)?

    ALGN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.